| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.088 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.42 | 0.1 |